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Technology and things “high tech” are frequently men-
tioned in the public press. References to technology
range from advertisement of household appliances to
methods of conducting modern warfare. However, to be
precise and for the purposes of this discussion, the defi-
nition of technology is the body of knowledge available
to a civilization that is of use in fashioning implements,
practicing manual arts and skills, and extracting or col-
lecting materials.1
Surgical technologic development after the discovery of
anesthesia and the acceptance of antisepsis in the 19th
century essentially involved operative instrumentation.
Refinement of clamps, retractors, scalpels, and other
devices in use then continued into the 20th century.
Surgical efforts focused on ways to extirpate or correct
disease processes, and new innovative procedures were
developed. But the technology used to perform those
operations remained relatively unchanged for almost 100
years. Surgeons of the 1890s would not have been undu-
ly uncomfortable with the operating instruments of the
1990s. Technology, although important, did not drive sur-
gical practice.
However, since the last half of the 20th century and now
into the 21st century, medicine and surgery have become
technology-driven professions. Spectacular medical
achievements have been accomplished that have, in large
measure, been due to advances in technology. These
advances have enabled physicians to diagnose and treat
disease more accurately than ever before. Computerized
tomography (CT), magnetic resonance imaging (MRI),
and radioisotope studies have revolutionized the field of
diagnostic imaging. Ultrasound (US) has given gynecolo-
gists an office-based tool to accurately diagnose female
genital tract disease without ionizing radiation. Serum
channel autoanalyzers, surgical intensive care monitor-
ing, and cardiac pacemakers are other examples of tech-
nology that has advanced medical care.
The new technologies have not only enhanced the qual-
ity of life, but have, in many instances, extended it.
People throughout the world, particularly in developed
western countries, have come to expect, indeed to
demand, high-technology health care. But the advances
have come at a price; a very high price that has generat-
ed wrenching ethical and social debate. National health
expenditures in the United States for example, increased
from 26.9 billion dollars (5.1% gross national product) in
1960 to 949.4 billion dollars in 1994 or 13.7% of the gross
national product. The number of medical schools in the
United States increased from 86 in 1960 to 126 in 1994,
and the number of medical students increased from
30 288 in 1960 to 66 629 in 1994.2
And, the increase has not been confined to just the
United States. All major countries have experienced a
similar increase in demand for health services—demand
fueled in part by readily available worldwide communi-
cation through television and the Internet.
The cost of technological devices has also steadily
increased. Demand in many instances has outstripped
supply and in countries of limited means, supply (health-
care facilities, personnel, and supportive technologies)
may be nonexistent. The answer to the complex dilem-
ma of providing affordable health care has been elusive,
but technology, which has been part of the problem
driving up cost, may well be a part of the solution.
Industry’s experience with sustaining and disruptive
technologies provides tantalizing clues and perhaps an
answer to the quandary of health-care provision in a
technologically driven age.
A brief explanation of terms is in order. Sustaining inno-
vation (technology) is the improvement an industry cre-
ates as it introduces new and more advanced products to
serve more sophisticated customers at the high end of a
market. Disruptive innovations (technology) are defined
as cheaper, simpler, and more convenient products or
services that meet the needs of less-demanding cus-
tomers.3 For example, the invention of the printing press
(disruptive technology) put a large number of human
copiers of books out of business. The inexpensive,
portable camera developed by George Eastman a centu-
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ry ago disrupted the world of images by eliminating the
need for bulky glass plates, cameras, and individual dark
rooms that Matthew Brady and his peers were required
to use. The invention of electrophotography by Chester
Carlson in 1938, later called xerography (Xerox), revolu-
tionized the world of printing and decreased reliance on
printing professionals.
In each instance, technology, particularly cheaper, sim-
pler, and more convenient technology, disrupted the sta-
tus quo, diffused throughout society, and brought great
benefit to that segment served by the industry. Each par-
ticular technology that previously required more highly
skilled specialists enabled a larger population of less
skilled persons to do more of a task, in a more conven-
ient setting, and in a less expensive manner.3
Health care although not strictly an industry has ele-
ments of it that may be treated as one. For instance, the
management of disease may be classified into tiers of
complexity that range from the most simple to the very
intricate. In the lowest, most simple tier, an easily per-
formed test can yield an unambiguous diagnosis that
calls for a straightforward treatment plan. The manner of
arriving at a treatment plan in this setting is called a rule-
based process. A standard management of disease that all
experts agree upon exists in this tier. The application of
a rule-based process results in treatment that does not
require specialist input.
In the middle level of disease complexity, no single
piece of information yields a diagnosis. Rather, multiple
data points suggest a diagnosis and a treatment program
through a process of pattern recognition.
Finally, in the most complex disease states, the diagno-
sis is obscure and requires the collective experience and
judgment of a team of clinicians. Multiple tests are
required and the diagnosis and treatment is arrived at in
a problem-solving mode.3
It can be inferred from the above that for diseases in the
most simple stage, diagnosis and treatment can be man-
aged by well-trained nonphysicians and less highly
skilled clinicians. Application of the rule-based process
would evoke a proven therapeutic strategy and tech-
nologies would be used to facilitate management. For
example, a sore throat can be evaluated by a nonphysi-
cian and a throat culture (prepackaged kit) obtained.
Antibiotic therapy would be initiated upon receipt of the
culture report (for example, “Strep”) and a visit to the
more costly primary care physician would be eliminated.
In many instances, nurse practitioners and other non-
physician clinicians already function as autonomous
providers of patient care in these scenarios.4 A down-
ward migration of patients occurs to a simpler and less
costly setting.
Similarly with appropriate enabling technology (for
example, office-based ultrasound) many breast lumps
could be evaluated by a primary care physician. Multiple
data points (such as, history, physical examination, US
findings) would suggest a diagnosis through a process of
pattern recognition. If the breast lump were found to be
cystic, it would be managed conservatively with regular
primary care physician follow up and ultrasound studies.
Again, this represents a downward migration of patients
from specialized centers to a more convenient, less cost-
ly setting.
On the other hand, if a breast mass presented as a com-
plex or solid image on ultrasound, surgical referral would
be indicated. Radiological evaluation might be necessary.
A surgeon would see the patient and perhaps perform a
fine-needle aspiration biopsy using ultrasound-guided
techniques. The disease diagnosis would be established
in a problem-solving manner.
Overall, the use of disruptive technology (such as, throat
culture kits, ultrasound) would cause a net downward
migration of patients from costly centers to more con-
venient, less costly offices where patients would be seen
by less specialized (expensive) personnel. The technolo-
gy used would be disruptive of the status quo.
In a similar manner, the laparoscopic surgical technique
has permitted patients with abdominal and pelvic disease
to be treated with minimally invasive means. But,
because of reduced surgical trauma, these patients have
a reduced length of stay in the hospital. Laparoscopic
technology that is disruptive of classical open surgery
results in reduced length of hospital stay, less morbidity,
and less cost to the health-care system. Today, cholecys-
tectomy, oophorectomy, and other laparoscopic opera-
tive procedures can safely be performed in an outpatient
setting, which further reduces cost. Minimally invasive
technology has caused a disruption of the status quo that
(with proper management of resources) is capable of
reducing the cost of managing several surgical diseases.
These are but a few examples of the possible beneficial
effects of disruptive technology on the cost of health
care; many others exist. To make it work, it is necessary
for surgeons, gynecologists, and urologists to accept
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change in the practice of surgery. The fact that primary
care physicians can mange a great many patients with
breast lumps does not necessarily mean a diminution in
the overall incidence of breast disease or the number of
cases that require surgical intervention. The shift to out-
patient surgery does not change the number of cases per-
formed by surgeons.
The lesson to be learned is that we must embrace change
and learn to manage patients in the most cost-effective
manner using appropriate technology. The number of
patients that rightly require surgical intervention will not
change. With continual increase in the population, the
number of patients requiring surgical therapy can be
expected to increase. Outpatient surgery can be per-
formed safely, and technology to enable this shift from
inpatient to outpatient service is available.
Surgeons, however, need to partner with hospitals to
assure that establishing an outpatient center does not
conflict with the need to maintain hospitals as a commu-
nity resource. Surgeons need to be involved in negotia-
tions with payers to assure that reimbursement is com-
mensurate with the service rendered. Finally, surgeons
need to be involved with the government to assure that
lawmakers understand the immense impact of their deci-
sions regarding Medicare payment issues and graduate
medical education funding. Practicing surgeons are a
vital resource, and a compelling need exists to nurture
them and to provide for a future generation of surgeons
to serve our communities and our country.
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